Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. | J Transl Med | 2022 | 35436939 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target. | Front Oncol | 2022 | 35433424 | PubTator, text mining | PubMed |
| High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses. | Front Pharmacol | 2022 | 35431930 | PubTator, text mining | PubMed |
| SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. | BMC Cancer | 2022 | 35421944 | PubTator, text mining | PubMed |
| Microglia/macrophage-derived human CCL18 promotes glioma progression via CCR8-ACP5 axis analyzed in humanized slice model. | Cell Rep | 2022 | 35417708 | PubTator, text mining | PubMed |
| Comparative Analysis of Transcriptional Responses to Genotoxic and Non-Genotoxic Agents in the Blood Cell Model TK6 and the Liver Model HepaRG. | Int J Mol Sci | 2022 | 35408779 | PubTator, text mining | PubMed |
| Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders. | Gastroenterol Rep (Oxf) | 2022 | 35401986 | PubTator, text mining | PubMed |
| ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer. | Front Cell Dev Biol | 2022 | 35399517 | PubTator, text mining | PubMed |
| Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment. | Front Immunol | 2022 | 35392073 | PubTator, text mining | PubMed |
| Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. | J Immunother Cancer | 2022 | 35387780 | PubTator, text mining | PubMed |
| ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma. | J Clin Lab Anal | 2022 | 35373393 | PubTator, text mining | PubMed |
| MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas. | Front Oncol | 2022 | 35372062 | PubTator, text mining | PubMed |
| Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. | Front Oncol | 2022 | 35372047 | PubTator, text mining | PubMed |
| Integrative Transcriptomics and Proteomics Analysis Provide a Deep Insight Into Bovine Viral Diarrhea Virus-Host Interactions During BVDV Infection. | Front Immunol | 2022 | 35371109 | PubTator, text mining | PubMed |
| Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy. | Front Immunol | 2022 | 35371055 | PubTator, text mining | PubMed |
| Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza. | Front Immunol | 2022 | 35371005 | PubTator, text mining | PubMed |
| Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy. | Front Neurol | 2022 | 35370925 | PubTator, text mining | PubMed |
| A Set of Experimentally Validated Decoys for the Human CC Chemokine Receptor 7 (CCR7) Obtained by Virtual Screening. | Front Pharmacol | 2022 | 35370691 | PubTator, text mining | PubMed |
| CEMIP as a potential biomarker and therapeutic target for breast cancer patients. | Int J Med Sci | 2022 | 35370456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=35